Celebrex (Celecoxib) is a widely used non-steroidal anti-inflammatory drug (NSAID) for the treatment of osteoarthritis (OA) and rheumatoid arthritis (RA) in adults and children over 12 years old. It is available in various strengths, including 200 mg capsules. The benefits of Celebrex in OA treatment include a reduction in fever and inflammation, which in turn can lead to improved mobility, faster healing, and more sustained pain relief. As a result, it is often preferred by patients who have experienced pain during NSAID treatment or in those who are allergic to aspirin or other NSAIDs.
Celebrex is known to be effective in reducing pain and inflammation. However, there are some potential benefits that you should be aware of before starting this medication:
Celebrex works by blocking the production of certain chemicals in the body that cause pain and inflammation. It does this by blocking an enzyme called COX-2 that breaks down the cyclooxygenase enzyme. COX-2 can also break down the enzymes that are responsible for producing pain and inflammation. Celebrex works by blocking the enzyme COX-2, which leads to its inhibition of platelet aggregation. As a result, Celebrex is able to reduce pain and inflammation, and therefore the risk of heart attack, stroke, and kidney disease.
Celebrex is indicated in OA treatment:
Like all medications, Celebrex can cause side effects in some patients. The most common side effects include:
It is important to be aware of these side effects and inform your doctor if they persist or worsen:
In rare cases, Celebrex can cause more serious side effects. These include:
These side effects are usually mild and resolve without medical intervention. However, if they persist or worsen, seek immediate medical attention.
If you are allergic to aspirin or other NSAIDs, Celebrex may not be suitable for you or may cause an allergic reaction (anaphylactic shock). In addition, your doctor will monitor you regularly for any signs of an allergic reaction and may adjust your dosage if necessary.
In addition, you should also be aware of signs of allergic reaction:
If you have a history of heart disease, Celebrex may not be suitable for you or may cause an increased risk of heart attack, stroke, or kidney failure.
If you are taking medications that could interact with Celebrex, your doctor may recommend a reduced dosage of Celebrex that you can take with Celebrex. This can be especially important for patients who are taking oral contraceptives, or who are taking other medications. For example, if you have kidney disease, Celebrex may not be suitable for you or may cause an increased risk of kidney failure.
CELEBREX 200MG CAPSULE contains Celecoxib which belongs to group of medicines called Non-steroidal anti-inflammatory drugs. CELEBREX 200MG CAPSULE is used in adults to manage osteoarthritis (degenerative joint disease), rheumatoid arthritis (inflammatory disease of joints), ankylosing spondylitis (chronic back pain), acute pain and primary dysmenorrhea (menstrual cramps).
CELEBREX 200MG CAPSULE is also used to manage juvenile rheumatoid arthritis (in children aged 2 years and above).
CELEBREX 200MG CAPSULE is not recommended for use in patients allergic to Celecoxib, sulfonamides, aspirin and/or other NSAIDs. It is also not recommended for use in patients with/had a history of an ulcer in stomach/intestines, bleeding in stomach/intestines, blood circulation problems (such as peripheral arterial disease), red itchy welts, inflammatory disease of the intestines (such as ulcerative colitis/Crohn’s disease).
The medicine is also not indicted for use in patients suffering from lung problems (such as asthma), heart diseases (such as heart failure, recent heart attack, heart block), severe liver disease (such as advanced hepatic insufficiency) and/or kidney disease (such as advanced renal insufficiency).
Before taking CELEBREX 200MG CAPSULE, inform your doctor if you have diabetes, raised blood pressure, increased cholesterol, signs of fluid retention (such as swollen ankles and feet) and/or hyperkalemia (increased potassium level in blood).
CELEBREX 200MG CAPSULE is not recommended for use in pregnant and breast-feeding women.
CELEBREX 200MG CAPSULE should be used with caution in children and adolescents (aged 2 to 17 years) to manage only juvenile rheumatoid arthritis and is advised to be used with caution in elderly patients (aged 65 years/above) after consulting the doctor.
The most common side effects of taking CELEBREX 200MG CAPSULE are high blood pressure, shortness of breath, sore throat, cough, headache, nausea and dizziness. Consult your doctor if any of these symptoms worsen.
References...asproven.
NEW YORK -- A new study finds that an over-the-counter (OTC) drug may help reduce the risk of Alzheimer's disease.
Researchers from the University of Minnesota examined the effect of an OTC drug, Celebrex, on the risk of Alzheimer's disease in patients taking the same dosage for up to a year.
The study showed that patients taking Celebrex for up to a year had an 8.4 times higher risk of developing the disease compared with patients who took the drug alone.
The drug, a Celebrex anti-inflammatory drug, is only FDA-approved for the treatment of arthritis. It was originally developed by Pfizer and is sold by Johnson & Johnson, a pharmaceutical company that makes the pills.
Researchers found that patients taking the Celebrex for a year had a 10.5 percent higher risk of Alzheimer's disease compared with patients who took the drug alone.
They also found that patients who took the Celebrex had a significantly higher incidence of Alzheimer's disease. These findings suggest that Celebrex may help reduce the risk of Alzheimer's disease in patients who have not yet been diagnosed with the disease.
The study, published in the Journal of the American Medical Association, examined more than 10,000 participants over a 12-year period. The results indicated that patients taking Celebrex for a year had a significantly higher incidence of Alzheimer's disease compared with patients who took the drug alone.
The study, published in the journal Lancet Aging, was conducted by the University of Minnesota. The study was funded by the National Institute of Neurological and Cell and Stroke Research, the National Institute on Aging, the National Institute on Aging, the American College of Clinical and Geriatric Neurology Network, and the National Institute on Aging’s National Institute on Aging Collaborative Research Network.
The study was conducted to identify a drug that may help patients with Alzheimer's who have not yet been diagnosed with the disease.
"Our findings suggest that, if taken as directed, Celebrex may be an effective treatment for Alzheimer's patients who have not yet been diagnosed with the disease," said lead author Dr. Emily Johnson, a professor of at the University of Minnesota and a researcher at the Cleveland Clinic.
Johnson is director of the National Institute of Neurological Disorders and Stroke, and senior author of the study, published in the May 2020 issue of the journal, Lancet Aging.
The drug, which is sold under the brand name Celebrex, has been used in clinical trials to reduce the risk of Alzheimer's disease.
The researchers found that patients taking the drug for a year had a 10.5 percent higher risk of developing the disease compared with patients who took the drug alone.
Researchers also found that patients taking Celebrex for a year had a significantly higher incidence of Alzheimer's disease. They also discovered that the drug reduced the risk of Alzheimer's in patients who had not yet been diagnosed with the disease.
They noted that the study does not have a control group because the control group was recruited from people who are not diagnosed with Alzheimer's disease.
The study was conducted by the University of Minnesota and was funded by the National Institute of Neurological Disorders and Stroke, the National Institute on Aging, the National Institutes of Health, the National Institute on Aging's National Institute on Aging Collaborative Research Network, and Johnson & Johnson.
Johnson and her team were recruited from approximately 1,400 people who have been diagnosed with Alzheimer's disease.
They also were from the U. S. and were enrolled in a phase 3 trial evaluating Celebrex, a pain reliever medication, over a 12-month period in the U. They were also enrolled in a phase 2 study of Celebrex, which was to be conducted in the U.
The trial was designed to enroll people who were between 18 and 64 years old. Participants were randomized in a 1:1 ratio to receive either Celebrex, 200 mg, or placebo for 12 months, or a placebo for the same period in a randomized fashion. Patients were then followed for the entire 12-month period. Participants who met the inclusion criteria were invited to take the trial.
In a separate randomized control trial, Johnson and her team conducted in the U. a 12-month extension of the trial, in which participants were followed for the entire 12-month period. Participants who met the inclusion criteria were then randomized to receive either Celebrex, 200 mg, or placebo for 12 months.
CELEBREX 200MG CAPSULE contains Celecoxib which belongs to group of medicines called Non-steroidal anti-inflammatory drugs. CELEBREX 200MG CAPSULE is used in adults to manage osteoarthritis (degenerative joint disease), rheumatoid arthritis (inflammatory disease of joints), ankylosing spondylitis (chronic back pain), acute pain and primary dysmenorrhea (menstrual cramps).
CELEBREX 200MG CAPSULE is also used to manage juvenile rheumatoid arthritis (in children aged 2 years and above).
CELEBREX 200MG CAPSULE is not recommended for use in patients allergic to Celecoxib, sulfonamides, aspirin and/or other NSAIDs. It is also not recommended for use in patients with/had a history of an ulcer in stomach/intestines, bleeding in stomach/intestines, blood circulation problems (such as peripheral arterial disease), red itchy welts, inflammatory disease of the intestines (such as ulcerative colitis/Crohn’s disease).
The medicine is also not indicted for use in patients suffering from lung problems (such as asthma), heart diseases (such as heart failure, recent heart attack, heart block), severe liver disease (such as advanced hepatic insufficiency) and/or kidney disease (such as advanced renal insufficiency).
Before taking CELEBREX 200MG CAPSULE, inform your doctor if you have diabetes, raised blood pressure, increased cholesterol, signs of fluid retention (such as swollen ankles and feet) and/or hyperkalemia (increased potassium level in blood).
CELEBREX 200MG CAPSULE is not recommended for use in pregnant and breast-feeding women.
CELEBREX 200MG CAPSULE should be used with caution in children and adolescents (aged 2 to 17 years) to manage only juvenile rheumatoid arthritis and is advised to be used with caution in elderly patients (aged 65 years/above) after consulting the doctor.
The most common side effects of taking CELEBREX 200MG CAPSULE are high blood pressure, shortness of breath, sore throat, cough, headache, nausea and dizziness. Consult your doctor if any of these symptoms worsen.
The brand name for Celecoxib is CELEBREX 200MG CAPSULE, which is an NSAID. The side effects of CELEBREX 200MG CAPSULE are moderate to strongheaded, allergic-type reactions (such as swelling (difficulty swallowing or making speech), sudden numbness or weakness (redness in the face,tangent of the tongue) and depression. It also leads to kidney isoscrayed kidney (serum/plasma)Creatinine (serum C 18) to volume loss.Allothers destroyed the original medicine.Do not take CELEBREX 200MG CAPSULE without consulting your doctor.How long does it take for CELEBREX 200MG CAPSULE to work (seen in 1-10 works). Do not take CELEBREX 200MG CAPSULE for more than 3 days. See end of the section on side effects.CELEBREX 200MG CAPSULE is contraindicated in the following cases:
You should not take CELEBREX 200MG CAPSULE if you are allergic to, or if you have heart problems, low blood pressure, stroke, heart failure, or heartogical problems.
Stade de France Pharmacy